Its Been Nice Lilly

Eli Lilly gave gave disappointing guidance for its out years, when drugs start running off patent. Luckily, I trimmed the position a few weeks back but unfortunately I still hold a position. I sold January 35 covered calls on my remaining shares.

No comments: